![](/img/cover-not-exists.png)
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
Shoshana Peller, Varda RotterVolume:
21
Year:
2003
Language:
english
Pages:
8
DOI:
10.1002/humu.10190
File:
PDF, 127 KB
english, 2003